影响重症患者连续脏替代疗法持续时间的因素:一项回顾性研究
Litao Guo1, Yandong Hu2, Qinjing Zeng1
1Department of Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
概括
抗凝方法显著影响重症患者的连续置换疗法 (CRRT) 持续时间. 与低分子量肝素 (LMWH) 相比,区域酸盐抗凝药 (RCA) 延长了CRRT.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 关键护理医学 关键护理医学
- 重症监护室的重症监护室的重症监护室.
背景情况:
- 持续置换疗法 (CRRT) 对重症患者至关重要.
- 了解影响CRRT持续时间的因素对于优化治疗至关重要.
- 抗凝血策略是CRRT疗效和持续时间的关键.
研究的目的:
- 分析影响重症患者CRRT持续时间的因素.
- 为了比较区域酸盐抗凝剂 (RCA) 与低分子量肝素 (LMWH) 对CRRT持续时间的影响.
- 为管理CRRT提供临床参考.
主要方法:
- 根据抗凝方法,患者被分为RCA和LMWH组.
- 收集了有关患者特征和CRRT参数的数据.
- 使用多变量线性回归分析来确定与CRRT时间相关的因素.
主要成果:
- 与LMWH组相比,RCA组的CRRT平均持续时间 (55.36 ± 22.57小时) 与LMWH组 (37.65 ± 27.09小时) 相比显著更长.
- RCA与更低的跨膜和过器压力有关.
- 抗凝模式,过器压力,ICU护士经验和机器前纤维素水平与CRRT持续时间有显著的相关性.
结论:
- 抗凝血方法是CRRT持续时间的主要决定因素.
- 过器压力,ICU护士的经验和纤维素水平也会影响CRRT持续时间.
- 研究结果为优化重症监护机构CRRT管理提供了见解.
相关概念视频
01:30Continuous Renal Replacement Therapy
54
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
54
01:20Acute Kidney Injury V: Interprofessional Care
30
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
30
01:11Renal Failure: Dose Adjustments
127
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
127
01:29Acute Kidney Injury III: Clinical Manifestations
44
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
44
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
46
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
46
01:17Factors Affecting Renal Clearance: Renal Impairment
123
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
123